Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
本文披露了
葡萄糖肽受体拮抗剂化合物。这些化合物可用于治疗2型糖尿病及相关疾病。此外,还包括药物组合物和治疗方法。